Prescribing Decision Support Tool Provision for NHS Mid and South Essex Integrated Care Board

The Prescribing Decision Support Tool enables prescribers (GPs, nurses and pharmacists) to understand the recommended local choices for prescribing. The implementation of this system creates significant savings through prescribers accepting the recommended switches and also educates prescribers to select those first choice products the next time these are prescribed. The tool also provides safety messages at the point of prescribing.

A contract to deliver the Prescribing Decision Support Tool across the Mid and South Essex Integrated Care Board (MSE ICB) area has been awarded to Optum. This contract has been awarded via the SBS Framework for Medicines Management Prescribing Decision Support Systems 2 (Reference SBS/19/AB/WAS/9389) following a review of all available tools within the Framework to fully explore the service offering to enable an informed decision to be made on which tool best meets the needs of the Contracting Authority and provides the best value for money solution, in line with the requirements of the Framework Agreement.

This contract commences 1st September 2022 for a period of 24 months until the 31st August 2024, with the option to extend the contract for a further 12 months. The total aggregate contract value is £1,008,450.00 (excluding VAT). The total aggregate contract value is £1,210,140.00 (inclusive of VAT) and this figure has been reflected in the award notice published by the Authority in line with Contracts Finder publishing guidance.

Additional information:

NHS Mid and South Essex Integrated Care Board have undertaken a compliant procurement process as a call-off from the SBS Framework to identify, and appoint, the most appropriate supplier to deliver the services in line with the commissioners requirements.